Previous close | 330.56 |
Open | 331.94 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 328.28 - 335.17 |
52-week range | 250.79 - 359.79 |
Volume | |
Avg. volume | 6,578 |
Market cap | 1.221B |
Beta (5Y monthly) | 0.91 |
PE ratio (TTM) | 0.62 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
AMSTERDAM, May 07, 2024--Stryker announced the completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.
Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024: First Quarter Results Reported net sales increased 9.7% to $5.2 billionOrganic net sales increased 10.0%Reported operating income margin of 18.5%Adjusted operating income margin(1) increased 80 bps to 21.9%Reported EPS increased 33.1% to $2.05Adjusted EPS(1) increased 16.8% to $2.50 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant C
Portage, Michigan, April 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s first quarter of fiscal year 2024, that ended March 31, 2024. Stryker will host a webcast at 4:30pm ET on Tuesday, April 30,